General Announcement::Press Release

Issuer & Securities

Issuer/ Manager
BIOCON BIOLOGICS GLOBAL PLC
Securities
BIOCONBIO US$800M6.67%N291009A - US090978AA56 - RJUB
BIOCONBIO US$800M6.67%N291009R - USG11185AA61 - KSEB
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
17-Sep-2025 18:55:46
Status
New
Announcement Sub Title
Press Release
Announcement Reference
SG250917OTHR8S7X
Submitted By (Co./ Ind. Name)
Biocon Biologics Limited / Akhilesh Nand
Designation
Company Secretary
Effective Date and Time of the event
17/09/2025 16:25:00
Description (Please provide a detailed description of the event in the box below)
Biocon Biologics Receives U.S. Food and Drug Administration Approval for Bosaya and Aukelso , Denosumab Biosimilars

Attachments

BBL_PR_USFDA_Deno_SGX_17092025.pdf
Total size =551K